Literature DB >> 24487434

Fas ligand-mediated immune surveillance by T cells is essential for the control of spontaneous B cell lymphomas.

Shoukat Afshar-Sterle1, Dimitra Zotos1, Nicholas J Bernard1, Anna K Scherger2, Lisa Rödling2, Amber E Alsop2, Jennifer Walker2, Frederick Masson2, Gabrielle T Belz2, Lynn M Corcoran2, Lorraine A O'Reilly2, Andreas Strasser2, Mark J Smyth3, Ricky Johnstone4, David M Tarlinton2, Stephen L Nutt2, Axel Kallies2.   

Abstract

Loss of function of the tumor suppressor gene PRDM1 (also known as BLIMP1) or deregulated expression of the oncogene BCL6 occurs in a large proportion of diffuse large B cell lymphoma (DLBCL) cases. However, targeted mutation of either gene in mice leads to only slow and infrequent development of malignant lymphoma, and despite frequent mutation of BCL6 in activated B cells of healthy individuals, lymphoma development is rare. Here we show that T cells prevent the development of overt lymphoma in mice caused by Blimp1 deficiency or overexpression of Bcl6 in the B cell lineage. Impairment of T cell control results in rapid development of DLBCL-like disease, which can be eradicated by polyclonal CD8(+) T cells in a T cell receptor-, CD28- and Fas ligand-dependent manner. Thus, malignant transformation of mature B cells requires mutations that impair intrinsic differentiation processes and permit escape from T cell-mediated tumor surveillance.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24487434     DOI: 10.1038/nm.3442

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  77 in total

1.  Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells.

Authors:  Susanne J Szabo; Brandon M Sullivan; Claudia Stemmann; Abhay R Satoskar; Barry P Sleckman; Laurie H Glimcher
Journal:  Science       Date:  2002-01-11       Impact factor: 47.728

2.  Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function.

Authors:  H W Mittrücker; T Matsuyama; A Grossman; T M Kündig; J Potter; A Shahinian; A Wakeham; B Patterson; P S Ohashi; T W Mak
Journal:  Science       Date:  1997-01-24       Impact factor: 47.728

3.  Identification of Pax5 target genes in early B cell differentiation.

Authors:  Clare Pridans; Melissa L Holmes; Matthew Polli; James M Wettenhall; Aleksandar Dakic; Lynn M Corcoran; Gordon K Smyth; Stephen L Nutt
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

4.  Adaptive immunity maintains occult cancer in an equilibrium state.

Authors:  Catherine M Koebel; William Vermi; Jeremy B Swann; Nadeen Zerafa; Scott J Rodig; Lloyd J Old; Mark J Smyth; Robert D Schreiber
Journal:  Nature       Date:  2007-11-18       Impact factor: 49.962

Review 5.  Spectrum of Epstein-Barr virus-associated diseases.

Authors:  J L Kutok; F Wang
Journal:  Annu Rev Pathol       Date:  2006       Impact factor: 23.472

6.  Multiple defects of immune cell function in mice with disrupted interferon-gamma genes.

Authors:  D K Dalton; S Pitts-Meek; S Keshav; I S Figari; A Bradley; T A Stewart
Journal:  Science       Date:  1993-03-19       Impact factor: 47.728

7.  Plasma cell ontogeny defined by quantitative changes in blimp-1 expression.

Authors:  Axel Kallies; Jhagvaral Hasbold; David M Tarlinton; Wendy Dietrich; Lynn M Corcoran; Philip D Hodgkin; Stephen L Nutt
Journal:  J Exp Med       Date:  2004-10-18       Impact factor: 14.307

8.  Distinct T cell receptor signaling requirements for perforin- or FasL-mediated cytotoxicity.

Authors:  M T Esser; B Krishnamurthy; V L Braciale
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

9.  Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma.

Authors:  Andreas Rosenwald; George Wright; Karen Leroy; Xin Yu; Philippe Gaulard; Randy D Gascoyne; Wing C Chan; Tong Zhao; Corinne Haioun; Timothy C Greiner; Dennis D Weisenburger; James C Lynch; Julie Vose; James O Armitage; Erlend B Smeland; Stein Kvaloy; Harald Holte; Jan Delabie; Elias Campo; Emili Montserrat; Armando Lopez-Guillermo; German Ott; H Konrad Muller-Hermelink; Joseph M Connors; Rita Braziel; Thomas M Grogan; Richard I Fisher; Thomas P Miller; Michael LeBlanc; Michael Chiorazzi; Hong Zhao; Liming Yang; John Powell; Wyndham H Wilson; Elaine S Jaffe; Richard Simon; Richard D Klausner; Louis M Staudt
Journal:  J Exp Med       Date:  2003-09-15       Impact factor: 14.307

10.  Innate immune surveillance of spontaneous B cell lymphomas by natural killer cells and gammadelta T cells.

Authors:  Shayna E A Street; Yoshihiro Hayakawa; Yifan Zhan; Andrew M Lew; Duncan MacGregor; Amanda M Jamieson; Andreas Diefenbach; Hideo Yagita; Dale I Godfrey; Mark J Smyth
Journal:  J Exp Med       Date:  2004-03-08       Impact factor: 14.307

View more
  41 in total

1.  Stromal immune infiltration in HIV-related diffuse large B-cell lymphoma is associated with HIV disease history and patient survival.

Authors:  Chun Chao; Lanfang Xu; Michael J Silverberg; Otoniel Martínez-Maza; Lie-Hong Chen; Brandon Castor; Donald I Abrams; Hongbin D Zha; Reina Haque; Jonathan Said
Journal:  AIDS       Date:  2015-09-24       Impact factor: 4.177

2.  ATM deficiency promotes development of murine B-cell lymphomas that resemble diffuse large B-cell lymphoma in humans.

Authors:  Karen S Hathcock; Hesed M Padilla-Nash; Jordi Camps; Dong-Mi Shin; Daniel Triner; Arthur L Shaffer; Robert W Maul; Seth M Steinberg; Patricia J Gearhart; Louis M Staudt; Herbert C Morse; Thomas Ried; Richard J Hodes
Journal:  Blood       Date:  2015-09-23       Impact factor: 22.113

Review 3.  The generation of antibody-secreting plasma cells.

Authors:  Stephen L Nutt; Philip D Hodgkin; David M Tarlinton; Lynn M Corcoran
Journal:  Nat Rev Immunol       Date:  2015-02-20       Impact factor: 53.106

Review 4.  T Cells and Regulated Cell Death: Kill or Be Killed.

Authors:  Johan Spetz; Adam G Presser; Kristopher A Sarosiek
Journal:  Int Rev Cell Mol Biol       Date:  2018-08-29       Impact factor: 6.813

5.  BCR-signaling-induced cell death demonstrates dependency on multiple BH3-only proteins in a murine model of B-cell lymphoma.

Authors:  M J Carter; K L Cox; S J Blakemore; Y D Bogdanov; L Happo; C L Scott; A Strasser; G K Packham; M S Cragg
Journal:  Cell Death Differ       Date:  2015-07-17       Impact factor: 15.828

6.  CXCR5(+) follicular cytotoxic T cells control viral infection in B cell follicles.

Authors:  Yew Ann Leong; Yaping Chen; Hong Sheng Ong; Di Wu; Kevin Man; Claire Deleage; Martina Minnich; Benjamin J Meckiff; Yunbo Wei; Zhaohua Hou; Dimitra Zotos; Kevin A Fenix; Anurag Atnerkar; Simon Preston; Jeffrey G Chipman; Greg J Beilman; Cody C Allison; Lei Sun; Peng Wang; Jiawei Xu; Jesse G Toe; Hao K Lu; Yong Tao; Umaimainthan Palendira; Alexander L Dent; Alan L Landay; Marc Pellegrini; Iain Comerford; Shaun R McColl; Timothy W Schacker; Heather M Long; Jacob D Estes; Meinrad Busslinger; Gabrielle T Belz; Sharon R Lewin; Axel Kallies; Di Yu
Journal:  Nat Immunol       Date:  2016-08-03       Impact factor: 25.606

7.  The genotype of the transporter associated with antigen processing gene affects susceptibility to colorectal cancer in Japanese.

Authors:  Takenori Yamauchi; Shouhei Takeuchi; Naoki Maehara; Yoshiki Kuroda
Journal:  Environ Health Prev Med       Date:  2014-05-07       Impact factor: 3.674

8.  Histone deacetylase inhibitor panobinostat induces calcineurin degradation in multiple myeloma.

Authors:  Yoichi Imai; Eri Ohta; Shu Takeda; Satoko Sunamura; Mariko Ishibashi; Hideto Tamura; Yan-Hua Wang; Atsuko Deguchi; Junji Tanaka; Yoshiro Maru; Toshiko Motoji
Journal:  JCI Insight       Date:  2016-04-21

9.  SUV39H1 regulates human colon carcinoma apoptosis and cell cycle to promote tumor growth.

Authors:  Chunwan Lu; John D Klement; Dafeng Yang; Thomas Albers; Iryna O Lebedyeva; Jennifer L Waller; Kebin Liu
Journal:  Cancer Lett       Date:  2020-02-12       Impact factor: 8.679

10.  Bortezomib Improves Adoptive T-cell Therapy by Sensitizing Cancer Cells to FasL Cytotoxicity.

Authors:  Anil Shanker; Samuel T Pellom; Duafalia F Dudimah; Menaka C Thounaojam; Rachel L de Kluyver; Alan D Brooks; Hideo Yagita; Daniel W McVicar; William J Murphy; Dan L Longo; Thomas J Sayers
Journal:  Cancer Res       Date:  2015-10-22       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.